Asahi Kasei Therapeutics Venture Capital
Overview
Asahi Kasei Therapeutics Venture Capital is an evergreen strategic venture fund that invests internationally in private, early-stage biopharmaceutical and biotech companies, focusing on innovative therapeutics and platforms.
Investments
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Asahi Kasei Therapeutics Venture Capital based?
Asahi Kasei Therapeutics Venture Capital is headquartered in Tokyo, Japan.
When was Asahi Kasei Therapeutics Venture Capital founded?
Asahi Kasei Therapeutics Venture Capital was founded in 2018.
How many portfolio companies does Asahi Kasei Therapeutics Venture Capital have?
Asahi Kasei Therapeutics Venture Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Asahi Kasei Therapeutics Venture Capital's portfolio?
Portfolio companies visible on Caplight include Glycomine, Azafaros.
What was Asahi Kasei Therapeutics Venture Capital's most recent investment shown here?
Asahi Kasei Therapeutics Venture Capital's most recent investment in this portfolio sample was in Azafaros in 2025.
What sectors does Asahi Kasei Therapeutics Venture Capital focus on?
Asahi Kasei Therapeutics Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Asahi Kasei Therapeutics Venture Capital focus on?
Asahi Kasei Therapeutics Venture Capital typically invests at the Mid stage.